News

India does not have the economic muscle to build GPU infrastructure, like the US or China. However, a growing pool of ...
Dipak KurmiTuberculosis (TB), long regarded as one of the world’s deadliest infectious diseases, is facing an unprecedented counter offensive in India. As the country shoulders the highest global TB ...
No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.
COVID-19 residual lung abnormality' should be used instead of 'interstitial lung abnormality' for describing post-COVID-19 abnormalities.
Experts representing multiple societies and institutions across 14 countries have published guidance for computed tomography ...